Author： Chène Patrick
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.11, Iss.6, 2001-06, pp. : 923-935
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
p53 as a target for improved cancer therapy
By Wiman K.G.
Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 2, 1999-06 ,pp. :
Access to resources
Recommend
P53 Family: At the Crossroads in Cancer Therapy
Current Medicinal Chemistry, Vol. 16, Iss. 32, 2009-11 ,pp. :
gp130: a promising drug target for cancer therapy
Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 11, 2013-11 ,pp. :
p73 as a Pharmaceutical Target for Cancer Therapy
Current Pharmaceutical Design, Vol. 17, Iss. 6, 2011-02 ,pp. :
Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?
Current Medicinal Chemistry, Vol. 21, Iss. 5, 2014-02 ,pp. :